Arsenic trioxide regulates the apoptosis of glioma cell and glioma stem cell via down-regulation of stem cell marker Sox2

被引:32
|
作者
Sun, Hui [1 ]
Zhang, Shaojun [1 ]
机构
[1] Affiliated Hosp 1, Bengbu Med Coll, Dept Neurosurg, Bengbu 233004, Anhui, Peoples R China
关键词
Arsenic trioxide; Sox2; Apoptosis; Glioma; Glioma stem cell; GENE-EXPRESSION; CYCLE ARREST; CARCINOMA; GROWTH; ASSOCIATION; PROGRESSION; INHIBITION; ACTIVATION; INVASION; LINES;
D O I
10.1016/j.bbrc.2011.06.060
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Knowledge of the mechanism by which arsenic trioxide exerts the anti-tumor effects may help in designing a more effective regimen for therapy. Transcription factor Sox2, a key gene implicated in maintaining the "stemness" of embryonic and adult stem cells, plays an important role in the carcinogenesis and maintenance of glioblastoma. Here, we found that the expression of Sox2 at transcriptional level was decreased during As2O3-induced glioma cell apoptosis. And, the ectopic expression of Sox2 attenuated the apoptotic effect of As2O3 on glioma cell. Furthermore. As2O3 inhibited the self-renewal of glioma stem cells, and efficiently induces the apoptosis of glioma stem cells, at least, partly through down-regulation of Sox2. These data identify a previously unrecognized mechanism of the anti-tumor effects of arsenic trioxide. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:692 / 697
页数:6
相关论文
共 50 条
  • [31] Arsenic trioxide regulates gastric cancer cell apoptosis by mediating cAMP
    Abudoureyimu, A.
    Muhemaitibake, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (03) : 612 - 617
  • [32] Arsenic trioxide induces apoptosis in B-cell chronic lymphocytic leukemic cells through down-regulation of survivin via the p53-dependent signaling pathway
    Zhang, Xiao-Hui
    Feng, Ru
    Lv, Meng
    Jiang, Qian
    Zhu, Hong-Hu
    Qing, Ya-Zhen
    Bao, Jia-Ling
    Huang, Xiao-Jun
    Zheng, X. Long
    LEUKEMIA RESEARCH, 2013, 37 (12) : 1719 - 1725
  • [33] Nanoparticles for Stem Cell Therapy Bioengineering in Glioma
    Ruiz-Garcia, Henry
    Alvarado-Estrada, Keila
    Krishnan, Sunil
    Quinones-Hinojosa, Alfredo
    Trifiletti, Daniel M.
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2020, 8
  • [34] Stem cell markers in glioma progression and recurrence
    Hattermann, Kirsten
    Flueh, Charlotte
    Engel, Dorothee
    Mehdorn, H. Maximilian
    Synowitz, Michael
    Mentlein, Rolf
    Held-Feindt, Janka
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (05) : 1899 - 1910
  • [35] Glioma Stem Cell Research for the Development of Immunotherapy
    Ji, Jianfei
    Black, Keith L.
    Yu, John S.
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2010, 21 (01) : 159 - +
  • [36] The pathological characteristics of glioma stem cell niches
    He, Hu
    Li, Ming Wu
    Niu, Chao Shi
    JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (01) : 121 - 127
  • [37] Remimazolan inhibits glioma cell growth and induces apoptosis through down-regulation of NF-κB pathway
    Xu, Wei
    Hu, Jiamei
    Liu, Weiwei
    Zhu, Qiong
    Gong, Xuan
    Zhu, Pengpeng
    Yang, Xiao
    Xia, Rui
    Xue, Rui
    IUBMB LIFE, 2021, 73 (02) : 341 - 348
  • [38] Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth
    Zhou, Wenchao
    Cheng, Lin
    Shi, Yu
    Ke, Susan Q.
    Huang, Zhi
    Fang, Xiaoguang
    Chu, Cheng-wei
    Xie, Qi
    Bian, Xiu-wu
    Rich, Jeremy N.
    Bao, Shideng
    ONCOTARGET, 2015, 6 (35) : 37300 - 37315
  • [39] CHD1L Regulates Cell Cycle, Apoptosis, and Migration in Glioma
    Sun, Jie
    Zhang, Li
    Zhao, Hongyu
    Qiu, Xiaojun
    Chen, Wenjuan
    Wang, Donglin
    Ban, Na
    Fan, Shaochen
    Shen, Chaoyan
    Xia, Xiaojie
    Ji, Bin
    Wang, Yuchan
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2016, 36 (04) : 565 - 576
  • [40] Circadian properties of cancer stem cells in glioma cell cultures and tumorspheres
    Sharma, Vishal Premdev
    Anderson, Nathan Thomas
    Geusz, Michael Eric
    CANCER LETTERS, 2014, 345 (01) : 65 - 74